Article

500,000 Women to be Offered Breast Cancer Drugs

Those most at risk should be eligible for preventative treatment to reduce the chances of it developing, NHS told. More than half a million women at risk of breast cancer should be offered drugs by the NHS for the first time to stop it developing, according to official health advice that could lead to a historic shift from treatment of the country's most common cancer to its prevention.

All women over 30 in England and Wales judged to be at moderate or high risk of breast cancer would be able to take one of two drugs to reduce their risk under the draft guideline drawn up by the National Institute for Health and Clinical Excellence (Nice).

Read the full story: http://bit.ly/Xzoldn

Source: Oncology Business Review

Related Videos
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Cathy Eng, MD, FACP, FASCO
Leigh Maria Ramos-Platt, MD
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Molly Dean, MSW, Siftwell
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo